ACQUIRED · 2019
Who Acquired NxStage Medical, Inc.?
Fresenius Medical Care AG & Co. KGaA · $1.93B· 29.7× EBITDA
The acquisition
NxStage Medical, Inc. was acquired by Fresenius Medical Care AG & Co. KGaA in 2019 for $1.93B. The deal was priced at 29.7× EBITDA / 4.00× revenue.
NxStage Medical, Inc. at time of acquisition
Revenue
$487.0M
EBITDA
$65.0M
Deal value
$1.93B
EV / EBITDA
29.7×
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from SEC Fairness Opinion. Primary source. Full deal page.
Citation: ExitValue.ai. (2019). NxStage Medical, Inc. acquired by Fresenius Medical Care AG & Co. KGaA. https://exitvalue.ai/acquired/nxstage-medical-inc